CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...
Phase 3
Cleveland, Ohio, United States and 17 other locations
blood sugar that sometimes happens when injecting insulin in Type 1 diabetes patients. Participants will use continuous glucose monitoring t...
Phase 2
Cleveland, Ohio, United States and 26 other locations
double-blind, placebo-controlled study of HTD1801 in adult subjects with non-alcoholic steatohepatitis and liver fibrosis who have type 2 diabetes...
Phase 2
Westlake, Ohio, United States and 47 other locations
The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes...
Phase 3
Cleveland, Ohio, United States and 79 other locations
This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...
Phase 3
Cleveland, Ohio, United States and 78 other locations
The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...
Phase 3
Cleveland, Ohio, United States and 654 other locations
Glycemic Improvement in Patients with Inadequately Controlled Type 2 Diabetes and Obesity, the STEP-1 Study.A multi-center, double-blinded, ...
Cleveland, Ohio, United States and 6 other locations
double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...
Phase 2
Beachwood, Ohio, United States and 117 other locations
This is a randomized, masked, active-controlled, parallel-group, multi-center study that will assess the efficacy of ILUVIEN as a baseline therapy in...
Phase 4
Cleveland, Ohio, United States and 39 other locations
delivery method and continuous glucose monitoring (CGM) during a 13-week study period in individuals ≥14 years old with cystic fibrosis-related diabetes...
Phase 3
Cleveland, Ohio, United States and 8 other locations
Clinical trials
Research sites
Resources
Legal